February 20, 2026

Survival Outcomes With or Without Bilateral Risk-Reducing Mastectomy in BRCA1/BRCA2 Pathogenic Variant Carriers

In a UK study reported in the Journal of Clinical Oncology, Gandhi et al found that whereas breast cancer incidence was reduced with bilateral risk-reducing mastectomy among women carrying BRCA1/BRCA2...

The ASCO Post

February 20, 2026

CLL/SLL: FDA Approves Combination of Acalabrutinib and Venetoclax

The ASCO Post

February 20, 2026

AI Tool Classifies Pediatric Brain Tumors via Liquid Biopsy

The ASCO Post

February 19, 2026

High Response Rates With Front-Line Pivekimab Sunirine in BPDCN

The ASCO Post

April 10, 2026

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

The ASCO Post

April 10, 2026

How AI Is Already Having a Significant Impact on Cancer Care

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

April 10, 2026

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

The ASCO Post

April 10, 2026

How AI Is Already Having a Significant Impact on Cancer Care

The ASCO Post

April 09, 2026

In Celebration of a Decades-Long Journey of Discovery and Innovation

The ASCO Post

April 09, 2026

How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs

The ASCO Post

April 09, 2026

Japanese Study Looks at Rates of Cancer Therapy–Related AML

The ASCO Post

April 08, 2026

Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

2026 ASCO GU

April 10, 2026

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

The ASCO Post

April 07, 2026

Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?

The ASCO Post

April 07, 2026

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The ASCO Post

2026 ASCO GI

April 03, 2026

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

The ASCO Post

April 01, 2026

Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer

The ASCO Post

March 24, 2026

No Recurrence-Free Survival Benefit With Adjuvant Pembrolizumab in Hepatocellular Carcinoma

The ASCO Post

SABCS 2025

April 03, 2026

HER2CLIMB-05 Study: Tucatinib Enhances Progression-Free Survival as First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

The ASCO Post

March 10, 2026

SABCS 2025: High-Level Review of Select Data

The ASCO Post

December 11, 2025

P-RAD Trial Shows Increased T-Cell Infiltration With Preoperative Radiation Added to Anti–PD-1 Therapy in Early Breast Cancer

The ASCO Post

Clinical Guidelines

April 08, 2026

Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis

The ASCO Post

April 07, 2026

Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?

The ASCO Post

April 07, 2026

Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria

The ASCO Post

April 06, 2026

Fullerene Cream vs Trolamine Cream in Reducing Acute Radiation Dermatitis From Radiation Therapy for Head and Neck Cancer

The ASCO Post

Commentary & Perspectives

April 09, 2026

In Celebration of a Decades-Long Journey of Discovery and Innovation

The ASCO Post

March 31, 2026

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

The ASCO Post

March 25, 2026

How to Increase Organ Donations in the U.S.: Education and Financial Aid Are Key

Keck Medicine of USC

March 24, 2026

Forgotten Lessons From South Africa

The ASCO Post

FDA & Government News

March 24, 2026

FDA Approves Teclistamab and Daratumumab For Relapsed or Refractory Multiple Myeloma

The ASCO Post

March 23, 2026

FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma

The ASCO Post

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

Business Management

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

High Response Rates With Front-Line Pivekimab Sunirine in BPDCN

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

How AI Is Already Having a Significant Impact on Cancer Care

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

2026 ASCO GU

2026 ASCO GI

SABCS 2025

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management